Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

225 projects found matching your search criteria :

  1. New amide derivatives of cinnamic acid as a carbonyl reductase inhibitors, which modulate the activity of doxorubicin - ...

    Call: SONATA 11 , Panel: NZ7

    Principal investigator: dr Paulina Koczurkiewicz-Adamczyk

    Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

  2. Long non-coding RNAs (lncRNA) as treatment efficacy markers in patients with advanced melanoma harboring BRAF mutation.

    Call: OPUS 11 , Panel: NZ7

    Principal investigator: dr hab. Jacek Mackiewicz

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Nauk o Zdrowiu

  3. Immunoliposomal form of simvastatin - an attempt to use in the treatment of EGFR-dependent tumors.

    Call: OPUS 11 , Panel: NZ7

    Principal investigator: prof. Aleksander Sikorski

    Uniwersytet Wrocławski, Wydział Biotechnologii

  4. Evaluation of novel, synergistic drug combinations for the treatment of B cell malignancies

    Call: OPUS 11 , Panel: NZ7

    Principal investigator: dr Małgorzata Firczuk

    Warszawski Uniwersytet Medyczny, Wydział Lekarski

  5. How HPV16 infection influences EGFR/PI3K/AKT/mTOR pathway in squamous cell cancer of head and neck?

    Call: PRELUDIUM 11 , Panel: NZ5

    Principal investigator: Anna Janecka-Widła

    Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy, Oddział w Krakowie

  6. Biased inverse agonists of 5-HT6 receptor and dual 5-HT6/MAO-B inhibitors - in search for new therapeutic approaches for...

    Call: OPUS 11 , Panel: NZ7

    Principal investigator: prof. Paweł Zajdel

    Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

  7. Importance of cyclin F-RRM2 axis in drug-resistance of melanoma cells with different degree of aggressiveness - in vitro...

    Call: OPUS 11 , Panel: NZ7

    Principal investigator: prof. Alina Grzanka

    Uniwersytet Mikołaja Kopernika, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Wydział Lekarski

  8. The importance of interaction between NMDA and AMPA receptors and scaffolding proteins in the excitatory synaptic in the...

    Call: OPUS 11 , Panel: NZ7

    Principal investigator: dr hab. Magdalena Sowa-Kućma

    Uniwersytet Rzeszowski, Kolegium Nauk Medycznych

  9. Drinking water treatment residue as an amendment for sewage sludge used as a pretreatment for their safe utilization for...

    Call: PRELUDIUM 11 , Panel: ST10

    Principal investigator: Rafał Gałązka

    Instytut Uprawy Nawożenia i Gleboznawstwa - Państwowy Instytut Badawczy

  10. Mechanical properties improvement of elements produced from aluminium cast alloys, heat treated by appliance of surface ...

    Call: OPUS 1 , Panel: ST8

    Principal investigator: dr hab. Krzysztof Labisz

    Politechnika Śląska, Wydział Mechaniczny Technologiczny

  11. Effects of physical activity on osteoblastogenesis - the role of sclerostin

    Call: PRELUDIUM 1 , Panel: NZ7

    Principal investigator: Małgorzata Janik

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  12. Verification of the hypothesis of oxidative stress, apoptosis and immune factor as the mechanisms responsible for the po...

    Call: OPUS 10 , Panel: NZ5

    Principal investigator: dr hab. Monika Frączek

    Instytut Genetyki Człowieka Polskiej Akademii Nauk

  13. Selected indicators of health status and quality of life monitored during different rehabilitation procedures in post-se...

    Call: OPUS 10 , Panel: NZ7

    Principal investigator: dr hab. Zbigniew Szyguła

    Akademia Wychowania Fizycznego im. Bronisława Czecha w Krakowie, Wydział Rehabilitacji Ruchowej

  14. The effect of resveratrol in non-obese rats with genetically determined type 2 diabetes.

    Call: OPUS 10 , Panel: NZ7

    Principal investigator: dr hab. Katarzyna Szkudelska

    Uniwersytet Przyrodniczy w Poznaniu, Wydział Medycyny Weterynaryjnej i Nauk o Zwierzętach

  15. Search for the functionally selective 5-HT1A receptor agonists as new pharmacological tools in the development of treatm...

    Call: OPUS 10 , Panel: NZ7

    Principal investigator: prof. Marcin Kołaczkowski

    Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

  16. Design, synthesis and biological evaluation of the new steroid sulfatase (STS) inhibitors based on sulfamate analogs con...

    Call: PRELUDIUM 10 , Panel: NZ7

    Principal investigator: Mateusz Daśko

    Politechnika Gdańska, Wydział Chemiczny

  17. 5-HT6 receptor ligands as addition to antipsychotic therapy in schizophrenia - an impact on body weight, metabolic param...

    Call: OPUS 10 , Panel: NZ7

    Principal investigator: prof. Anna Wesołowska

    Uniwersytet Jagielloński Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

  18. Study of the distribution and depletion of metronidazole and oxytetracycline in bee products after experimental treatmen...

    Call: OPUS 10 , Panel: NZ7

    Principal investigator: dr hab. Kamila Mitrowska

    Państwowy Instytut Weterynaryjny - Państwowy Instytut Badawczy

  19. Chemopreventive potential of melanoidins isolated from heated potato fiber Potex. An in vitro study in colon carcinoma c...

    Call: PRELUDIUM 1 , Panel: NZ5

    Principal investigator: Ewa Langner

    Instytut Medycyny Wsi im. Witolda Chodźki

  20. Identification of biomarkers of individual radiochemotherapy toxicity and efficacy in patients with head and neck cancer...

    Call: OPUS 9 , Panel: NZ5

    Principal investigator: prof. Krzysztof Składowski

    Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy, Oddział w Gliwicach

  21. The influence of tauroursodeoxycholic acid (TUDCA) on the reduction of ER stress in chondrocyte cells - as a new directi...

    Call: PRELUDIUM 9 , Panel: NZ7

    Principal investigator: Magdalena Kusaczuk

    Uniwersytet Medyczny w Białymstoku, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej

  22. Investigation of the effects and mechanisms of action of Deep Brain Stimulation in two animal models of treatment-resist...

    Call: OPUS 9 , Panel: NZ7

    Principal investigator: prof. Mariusz Papp

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  23. Ability of CRISPR/dCas9 system and cell-penetrating proteins as the aim of prevention against coronary artery restenosis...

    Call: SONATA 9 , Panel: NZ7

    Principal investigator: dr Maciej Gagat

    Uniwersytet Mikołaja Kopernika, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Wydział Lekarski

  24. Optimization of systemic infections treatment in patients receiving parenteral nutrition - stability and compatibility s...

    Call: SONATA 9 , Panel: NZ7

    Principal investigator: dr Katarzyna Dettlaff

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

  25. Investigation of the relationship between telomerase activity and the mechanism of cell death induction in head and neck...

    Call: PRELUDIUM 9 , Panel: NZ5

    Principal investigator: Wojciech Barczak

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Lekarski II